The efficacy and safety of Remibrutinib in patients with Chronic Spontaneous Urticaria: A systematic review and meta-analysis of randomized controlled trials

Published: 25 June 2025| Version 1 | DOI: 10.17632/c3nnphrr26.1
Contributor:
Hicham Titou

Description

Recent clinical trials are exploring new therapies for chronic spontaneous urticaria (CSU). We perform a meta-analysis to review the efficacy and safety of remibrutinib for the treatment of CSU.

Files

Institutions

  • Universite Cadi Ayyad

Categories

Urticaria

Licence